Kingdon Capital Management, L.L.C. Scynexis Inc Transaction History
Kingdon Capital Management, L.L.C.
- $862 Million
- Q2 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Scynexis Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 2,237,048 shares of SCYX stock, worth $3.42 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
2,237,048
Previous 2,237,048
-0.0%
Holding current value
$3.42 Million
Previous $3.29 Million
36.07%
% of portfolio
0.52%
Previous 0.4%
Shares
9 transactions
Others Institutions Holding SCYX
# of Institutions
58Shares Held
14.5MCall Options Held
34KPut Options Held
5K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$6.45 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$2.58 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$2.22 Million0.14% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$849,9990.7% of portfolio
-
D.A. Davidson & Co.549KShares$840,3030.01% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $50M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...